Thomas v. Takeda Pharmaceuticals USA, Inc. et al

Filing 10

ORDER Granting Joint 9 Motion for a Stay Pending the Judicial Panel of Multidistrict Litigation's Resolution of the Motion to Transfer signed by Chief Judge Lawrence J. O'Neill on 01/10/2017. (Flores, E)

Download PDF
1 2 IN THE UNITED STATES DISTRICT COURT 3 FOR THE EASTERN DISTRICT OF CALIFORNIA 4 5 SHARRON THOMAS, 6 Plaintiff, 7 9 10 11 12 13 14 15 16 Hon. Lawrence J. O’Neill Courtroom 4 v. 8 TAKEDA PHARMACEUTICALS USA, INC., TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS INTERNATIONAL INC.; TAKEDA DEVELOPMENT CENTER AMERICAS, INC.; TAKEDA GMBH; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICAL COMPANY LIMITED, Defendants. 17 CASE NO. 1:16-CV-01566-LJOEPGx ORDER GRANTING JOINT MOTION FOR A STAY PENDING THE JUDICIAL PANEL ON MULTIDISTRICT LITIGATION’S RESOLUTION OF THE MOTION TO TRANSFER PURSUANT TO 28 U.S.C. § 1407 Action Filed: October 14, 2016 Trial Date: None Set 18 19 The Joint Motion For A Stay Pending The Judicial Panel On Multidistrict 20 Litigation’s Resolution Of The Motion To Transfer Pursuant To 28 U.S.C. § 1407 21 submitted by the parties, Takeda Pharmaceuticals, U.S.A., Inc., Takeda 22 Pharmaceuticals International, Inc., Takeda Development Center Americas, Inc. 23 and Takeda Pharmaceuticals America, Inc. (“Takeda”) and Plaintiff Sharron 24 Thomas (“Plaintiff”) on January 9, 2017, the Court, having received all evidence 25 and the matter having been submitted, ORDERS as follows: 26 IT IS HEREBY ORDERED that: 27 1. 28 1 2 All proceedings in this action are stayed pending the decision of the Judicial Panel on Multidistrict Litigation (“JPML”) on the motion Plaintiff’s 1 counsel filed on October 17, 2016 to transfer this action and fifteen others to a 2 multidistrict litigation, which Plaintiff’s counsel requested be established in the 3 United States District Court for the Middle District of Louisiana. See Ex. 1, 4 Memorandum in Support of Plaintiffs’ Motion for Transfer of Actions to the 5 United States District Court for the Middle District of Louisiana Pursuant to 28 6 U.S.C. § 1407 and JPML Rule 7.2 for Coordinated Pretrial Proceedings; and Ex. 2, 7 In re: Proton-Pump Inhibitor Product Liability Litigation (MDL No. 2757), 8 Schedule of Actions. 9 2. The Scheduling Conference set for January 26, 2017, along with 10 corresponding deadlines for the parties to meet and confer and submit a Joint 11 Scheduling Report in advance of the Scheduling Conference, is adjourned, 12 including a stay of all corresponding deadlines for the parties to hold a discovery 13 conference and submit a Joint Scheduling Report, until after the JPML decides the 14 motion requesting an MDL. 15 16 17 IT IS SO ORDERED. Dated: January 10, 2017 /s/ Lawrence J. O’Neill _____ UNITED STATES CHIEF DISTRICT JUDGE 18 19 20 21 22 23 24 25 26 27 28 1 2

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?